Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy

Brain Imaging and Behavior

Volumn 7, Issue 4, 2013, Pages 501-510

  Kesler, Shelli R ^a,b   Watson, Christa ^a,c   Koovakkattu, Della ^a   Lee, Clement ^a   O'Hara, Ruth ^a   Mahaffey, Misty L ^b   Wefel, Jeffrey S ^d  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast Cancer; Chemotherapy; Cognition; MR Spectroscopy; Prefrontal Cortex

Indexed keywords

ANTINEOPLASTIC AGENT; CHOLINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; INOSITOL; METHOTREXATE; N ACETYLASPARTIC ACID; PACLITAXEL; TAMOXIFEN;

ADULT; ARTICLE; BRAIN METABOLISM; BREAST CANCER; CANCER PATIENT; CANCER SURVIVOR; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; HIGH RISK PATIENT; HUMAN; MEMORY; NEUROBIOLOGY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITY OF LIFE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHOLINE; COGNITION; FEMALE; HUMANS; INOSITOL; MIDDLE AGED; PREFRONTAL CORTEX; TREATMENT OUTCOME; UP-REGULATION;

EID: 84901364414     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-013-9228-1     Document Type: Article

References (69)

1. Aghakhani, A. and Chan, E.K., 2007. Test Reviews: Bracken, B. A., & Howell, K. (2004). Clinical Assessment of Depression. Odessa, FL: Psychological Assessment Resources. Journal of Psychoeducational Assessment. 25, 416-422.
2. Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. (2010). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. Journal of Clinical Oncology., 28, 4434-4440.
3. Arnsten, A. F. (2011). Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia. International Journal of Developmental Neuroscience: the official Journal of the International Society for Developmental Neuroscience., 29, 215-223.
4. Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998). Hopkins verbal learning test-revised: normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist., 12, 43-55.
5. Boripuntakul, S., Kothan, S., Methapatara, P., Munkhetvit, P., & Sungkarat, S. (2012). Short-term effects of cognitive training program for individuals with amnestic mild cognitive impairment: a pilot study. Physical & Occupational Therapy in Geriatrics., 30, 138-149.
6. Bozgeyik, Z., Burakgazi, G., Sen, Y., & Ogur, E. (2008). Age-related metabolic changes in the corpus callosum: assessment with MR spectroscopy. Diagnostic and Interventional Radiology., 14, 173-176.
7. Brown, M. S., Stemmer, S. M., Simon, J. H., Stears, J. C., Jones, R. B., Cagnoni, P. J., & Sheeder, J. L. (1998). White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. AJNR. American Journal of Neuroradiology., 19, 217-221.
8. Bruno, J., Hosseini, S. M., & Kesler, S. (2012). Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors. Neurobiol Dis., 48, 329-338.
9. Castellon, S. A., Ganz, P. A., Bower, J. E., Petersen, L., Abraham, L., & Greendale, G. A. (2004). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol., 26, 955-969.
10. Chang, K., Adleman, N., Dienes, K., Barnea-Goraly, N., Reiss, A., & Ketter, T. (2003). Decreased N-acetylaspartate in children with familial bipolar disorder. Biol Psychiatry., 53, 1059-1065.
11. Chang, K., Karchemskiy, A., Kelley, R., Howe, M., Garrett, A., Adleman, N., & Reiss, A. (2009). Effect of divalproex on brain morphometry, chemistry, and function in youth at high-risk for bipolar disorder: a pilot study. J Child Adolesc Psychopharmacol., 19, 51-59.
12. de Ruiter, M.B., Reneman, L., Boogerd, W., Veltman, D.J., Caan, M., Douaud, G., Lavini, C., Linn, S.C., Boven, E., van Dam, F.S. and Schagen, S.B. (2011a). Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Hum Brain Mapp.
13. de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., van Dam, F. S., Nederveen, A. J., Boven, E., & Schagen, S. B. (2011b). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp., 32, 1206-1219.
14. Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Van den Stock, J., Smeets, A., Christiaens, M. R., Leemans, A., Van Hecke, W., Vandenberghe, J., Vandenbulcke, M., & Sunaert, S. (2011). Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Human Brain Mapping., 32, 480-493.
15. Deprez, S., Amant, F., Smeets, A., Peeters, R., Leemans, A., Van Hecke, W., Verhoeven, J. S., Christiaens, M. R., Vandenberghe, J., Vandenbulcke, M., & Sunaert, S. (2012). Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol., 30, 274-281.
16. Diamond, A. (2011). Biological and social influences on cognitive control processes dependent on prefrontal cortex. Progress in Brain Research., 189, 319-339.
17. Elliott, R. (2003). Executive functions and their disorders. British Medical Bulletin., 65, 49-59.
18. Ernst, T., Chang, L., Cooray, D., Salvador, C., Jovicich, J., Walot, I., Boone, K., & Chlebowski, R. (2002). The effects of tamoxifen and estrogen on brain metabolism in elderly women. J Natl Cancer Inst., 94, 592-597.
19. Francis, P. T. (2003). Glutamatergic systems in Alzheimer's disease. Int J Geriatr Psychiatry., 18, S15-21.
20. Gamper, N., & Shapiro, M. S. (2007). Regulation of ion transport proteins by membrane phosphoinositides. Nature reviews. Neuroscience., 8, 921-934.
21. Ganz, P. A., Bower, J. E., Kwan, L., Castellon, S. A., Silverman, D. H. S., Geist, C., Breen, E. C., Irwin, M. R., & Cole, S. W. (2013). Does tumor necrosis factor-alpha (TNF-α) play a role in postchemotherapy cerebral dysfunction? Brain, Behavior, and Immunity., 30, S99-S108.
22. Heaton, R. K. (2004). Wisconsin card sorting test computer version 4-research edition (WCST:CV4). Odessa: Psychological Assessment Resources.
23. Henigsberg, N., Kalember, P., Hrabac, P., Rados, M., Bajs, M., Kovavic, Z., Loncar, M., & Madzar, T. (2011). 1-H MRS changes in dorsolateral prefrontal cortex after donepezil treatment in patients with mild to moderate Alzheimer's disease. Collegium Antropologicum., 35(Suppl 1), 159-162.
24. Homack, S., Lee, D., & Riccio, C. A. (2005). Test review: Delis-Kaplan executive function system. J Clin Exp Neuropsychol., 27, 599-609.
25. Hosseini, S. M., Koovakkattu, D., & Kesler, S. R. (2012). Altered small-world properties of gray matter networks in breast cancer. BMC Neurol., 12, 28.
26. Janelsins, M. C., Kohli, S., Mohile, S. G., Usuki, K., Ahles, T. A., & Morrow, G. R. (2011). An update on cancer-and chemotherapyrelated cognitive dysfunction: current status. Seminars in Oncology., 38, 431-438.
27. Jansen, C. E., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer., 104, 2222-2233.
28. Joshi, G., Aluise, C. D., Cole, M. P., Sultana, R., Pierce, W.M., Vore, M., St Clair, D. K., & Butterfield, D. A. (2010). Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain. Neuroscience., 166, 796-807.
29. Kesler, S. R., Bennett, F. C., Mahaffey, M. L., & Spiegel, D. (2009a). Regional brain activation during verbal declarative memory in metastatic breast cancer. Clin Cancer Res., 15, 6665-6673.
30. Kesler, S. R., Lightbody, A. A., & Reiss, A. L. (2009b). Cholinergic dysfunction in fragile X syndrome and potential intervention: a preliminary 1H MRS study. Am J Med Genet A., 149A, 403-407.
31. Kesler, S. R., Kent, J. S., & O'Hara, R. (2011). Prefrontal cortex and executive function impairments in primary breast cancer. Arch Neurol., 68, 1447-1453.
32. Kesler, S., Janelsins, M., Koovakkattu, D., Palesh, O., Mustian, K., Morrow, G., & Dhabhar, F. S. (2013). Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun., 30, S109-S116.
33. Koppelmans, V., de Ruiter, M.B., van der Lijn, F., Boogerd, W., Seynaeve, C., van der Lugt, A., Vrooman, H., Niessen, W.J., Breteler, M.M. and Schagen, S.B. (2011). Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat.
34. Leh, S. E., Petrides, M., & Strafella, A. P. (2010). The neural circuitry of executive functions in healthy subjects and Parkinson's disease. Neuropsychopharmacology., 35, 70-85.
35. Lemaitre, H., Goldman, A.L., Sambataro, F., Verchinski, B.A., Meyer-Lindenberg, A., Weinberger, D.R. and Mattay, V.S. (2010). Normal age-related brain morphometric changes: nonuniformity across cortical thickness, surface area and gray matter volume? Neurobiology of aging.
36. Maddock, R.J. and Buonocore, M.H. (2012). MR spectroscopic studies of the brain in psychiatric disorders. Current topics in behavioral neurosciences.
37. McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Research and Treatment., 123, 819-828.
38. McDonald, B.C., Conroy, S.K., Ahles, T.A., West, J.D. and Saykin, A.J. (2012a). Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. J Clin Oncol.
39. McDonald, B.C., Conroy, S.K., Smith, D.J., West, J.D. and Saykin, A.J. (2012b). Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study. Brain Behav Immun.
40. NCI. (2012, 09/24/2012). "Breast Cancer Risk in American Women. " Retrieved 01/30/2013, 2013, from http://www.cancer.gov/ cancertopics/factsheet/detection/probability-breast-cancer.
41. Newman, E. L., Gupta, K., Climer, J. R., Monaghan, C. K., & Hasselmo, M. E. (2012). Cholinergic modulation of cognitive processing: insights drawn from computational models. Front Behav Neurosci., 6, 24.
42. Ouimet, L. A., Stewart, A., Collins, B., Schindler, D., & Bielajew, C. (2009). Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models. J Clin Exp Neuropsychol., 31, 73-89.
43. Prescot, A. P., Locatelli, A. E., Renshaw, P. F., & Yurgelun-Todd, D. A. (2011). Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study. Neuroimage., 57, 69-75.
44. Provencher, S. (2001). Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR in Biomed., 14, 260-264.
45. Quesnel, C., Savard, J., & Ivers, H. (2009). Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat., 116, 113-123.
46. Roth, R. M., Isquith, P. K., & Gioia, G. (2005). Behavioral rating inventory of executive function-adult version. Lutz: Psychological Assessment Resources.
47. Schifitto, G., Deng, L., Yeh, T. M., Evans, S. R., Ernst, T., Zhong, J., & Clifford, D. (2011). Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals. J Neurovirol., 17, 17-25.
48. Schneider, P., Weber-Fahr, W., Schweinfurth, N., Ho, Y. J., Sartorius, A., Spanagel, R., & Pawlak, C. R. (2012). Central metabolite changes and activation of microglia after peripheral interleukin-2 challenge. Brain Behav Immun., 26, 277-283.
49. Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008). Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer., 8, 887-899.
50. Silverman, D. H., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., Waddell, K., Petersen, L., Phelps, M. E., & Ganz, P. A. (2007). Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat., 103, 303-311.
51. Stern, Y. (2009). Cognitive reserve. Neuropsychologia., 47, 2015-2028.
52. Stern, R. A., & White, T. (2005). NAB Categories Test. Lutz: Psychological Assessment Resources.
53. Stilley, C. S., Bender, C. M., Dunbar-Jacob, J., Sereika, S., & Ryan, C. M. (2010). The impact of cognitive function on medication management: three studies. Health Psychology: official Journal of the Division of Health Psychology, American Psychological Association., 29, 50-55.
54. Tangpong, J., Cole, M. P., Sultana, R., Joshi, G., Estus, S., Vore, M., St Clair, W., Ratanachaiyavong, S., St Clair, D. K., & Butterfield, D. A. (2006). Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity. Neurobiology of Disease., 23, 127-139.
55. Tangpong, J., Cole, M. P., Sultana, R., Estus, S., Vore, M., St Clair, W., Ratanachaiyavong, S., St Clair, D. K., & Butterfield, D. A. (2007). Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain. J Neurochem., 100, 191-201.
56. Tayebati, S. K., Tomassoni, D., Di Stefano, A., Sozio, P., Cerasa, L. S., & Amenta, F. (2011). Effect of choline-containing phospholipids on brain cholinergic transporters in the rat. Journal of the Neurological Sciences., 302, 49-57.
57. Troyer, A. K., & Rich, J. B. (2002). Psychometric properties of a new metamemory questionnaire for older adults. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences., 57, P19-P27.
58. Vardy, J. (2009). Cognitive function in breast cancer survivors. Cancer Treat Res., 151, 387-419.
59. Vehmanen, L., Elomaa, I., Blomqvist, C., & Saarto, T. (2006). Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. Journal of Clinical Oncology: official Journal of the American Society of Clinical Oncology., 24, 675-680.
60. Von Ah, D., Carpenter, J. S., Saykin, A., Monahan, P., Wu, J., Yu, M., Rebok, G., Ball, K., Schneider, B., Weaver, M., Tallman, E., & Unverzagt, F. (2012). Advanced cognitive training for breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat., 135, 799-809.
61. Wang, T., Xiao, S., Li, X., Ding, B., Ling, H., Chen, K. and Fang, Y. (2011). Using proton magnetic resonance spectroscopy to identify mild cognitive impairment. International psychogeriatrics/IPA. 1-9.
62. Wechsler, D. (2008). Wechsler adult intelligence scale fourth edition. San Antonio: The Psychological Corporation.
63. Wefel, J. S., & Schagen, S. B. (2012). Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep., 12, 267-275.
64. Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer., 100, 2292-2299.
65. Wefel, J. S., Saleeba, A. K., Buzdar, A. U., & Meyers, C. A. (2010). Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer., 116, 3348-3356.
66. Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011). International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. The Lancet Oncology., 12, 703-708.
67. Winocur, G., Binns, M. A., & Tannock, I. (2011). Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model. Neuropharmacology., 61, 1222-1228.
68. Yang, B., Akhter, S., Chaudhuri, A., & Kanmogne, G. D. (2009). HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling. Microvasc Res., 77, 212-219.
69. Yorek, M. A., Dunlap, J. A., Thomas, M. J., Cammarata, P. R., Zhou, C., & Lowe, W. L., Jr. (1998). Effect of TNF-alpha on SMIT mRNA levels and myo-inositol accumulation in cultured endothelial cells. Am J Physiol., 274, C58-71.